Log In
Print
BCIQ
Print
Print this Print this
 

Y-90 epratuzumab (hCD22, IMMU-102)

Also known as: LymphoCide (ex(90)Y) (Yttrium-90-labeled humanized antibody targeting CD22) (formerly (90)Y-LymphoCide, Epratuzumab)

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionYttrium-90-labeled humanized mAb targeting CD22
Molecular Target CD22
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today